R. Jude Samulski, Ph.D., was honored by the American Society of Gene + Cell Therapy (ASGCT) with its Founders Award at the ...

North Carolina Agricultural and Technical State University will collaborate with another historically Black college and ...

Durham-based BioCryst Pharmaceuticals, a global biotechnology company focused on developing and commercializing medicines for rare diseases, has signed a European licensing agreement for one of its ...

The Alexandria Center for Life Science - Durham North Campus (ACLS-D), at 42 Moore Drive, won the distinction. It’s located ...

Novartis announced a second investment in NC of $220M for a new facility on its Morrisville campus, focused on active pharmaceutical ingredient API manufacturing for solid dosage tablets, capsules, ...

Fresh off a new funding round, Durham startup Ten63 Therapeutics is looking to advance its technology platform that uses artificial intelligence to unlock discoveries for difficult-to-treat cancers.

Durham-based Priovant Therapeutics has announced positive results from its Phase 2 BEACON study evaluating brepocitinib in cutaneous sarcoidosis (CS). CS is an inflammatory granulomatous skin disease ...

Long-time Triangle ag-biotech executive Toni Bucci, Ph.D., has a clear vision for her new company, Sable Fermentation Inc.: Enable manufacturing and commercialization of agricultural and other ...

A California medical technology startup plans to expand the Research Triangle Park facility it bought in 2022, adding 50 jobs and spending up to $65 million on the project. Science Corp. in Alameda, ...

Over the summer, the Biomedical Emerging Technology Applications (BETA) Summer Fellows Industry Program provided six educators with an eight-week opportunity to learn what it is like to work at a ...

An Israeli pharmaceutical company with U.S. headquarters in Raleigh says it’s on track to seek regulatory approval for potentially lucrative new uses of its variation on a common gastrointestinal drug ...